Literature DB >> 26210937

Use of a force-sensing automated open field apparatus in a longitudinal study of multiple behavioral deficits in CAG140 Huntington's disease model mice.

Stephen C Fowler1, Nancy A Muma2.   

Abstract

Behavioral testing of mouse models of Huntington's disease (HD) is a key component of preclinical assessment for potential pharmacological intervention. An open field with a force plate floor was used to quantify numerous spontaneous behaviors in a slowly progressing model of HD. CAG140 (+/+, +/-, -/-) male and female mice were compared in a longitudinal study from 6 to 65 weeks of age. Distance traveled, wall rears, wall rear duration, number of low mobility bouts, in-place movements, number of high velocity runs, and gait parameters (stride rate, stride length, and velocity) were extracted from the ground reaction forces recorded in 20-min actometer sessions. Beginning at 11 weeks, HD mice (both +/- and +/+) were consistently hypoactive throughout testing. Robust hypoactivity at 39 weeks of age was not accompanied by gait disturbances. By 52 and 65 weeks of age the duration of wall rears increased and in-place tremor-like movements emerged at 65 weeks of age in the +/+, but not in the +/- HD mice. Taken together, these results suggest that hypoactivity preceding frank motor dysfunction is a characteristic of CAG140 mice that may correspond to low motivation to move seen clinically in the premanifest/prediagnostic stage in human HD. The results also show that the force plate method provides a means for tracking the progression of behavioral dysfunction in HD mice beyond the stage when locomotion is lost while enabling quantification of tremor-like and similar in-place behaviors without a change in instrumentation. Use of force plate actometry also minimizes testing-induced enrichment effects when batteries of different tests are carried out longitudinally.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CAG140 knock-in mouse; Distance traveled; Force plate; Gait; Huntington’s disease; Power spectra

Mesh:

Year:  2015        PMID: 26210937      PMCID: PMC4564309          DOI: 10.1016/j.bbr.2015.07.036

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  31 in total

Review 1.  Neural consequences of environmental enrichment.

Authors:  H van Praag; G Kempermann; F H Gage
Journal:  Nat Rev Neurosci       Date:  2000-12       Impact factor: 34.870

2.  Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease.

Authors:  Miriam A Hickey; Chunni Zhu; Vera Medvedeva; Nicholas R Franich; Michael S Levine; Marie-Françoise Chesselet
Journal:  Mol Cell Neurosci       Date:  2011-10-20       Impact factor: 4.314

3.  Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats.

Authors:  Aaron C Rising; Jia Xu; Aaron Carlson; Vincent V Napoli; Eileen M Denovan-Wright; Ronald J Mandel
Journal:  Exp Neurol       Date:  2010-12-28       Impact factor: 5.330

4.  Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.

Authors:  M A Hickey; A Kosmalska; J Enayati; R Cohen; S Zeitlin; M S Levine; M-F Chesselet
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

5.  Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease.

Authors:  Jennifer C Thompson; Jenny Harris; Andrea C Sollom; Cheryl L Stopford; Elizabeth Howard; Julie S Snowden; David Craufurd
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

6.  Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice.

Authors:  Y P Deng; T Wong; C Bricker-Anthony; B Deng; A Reiner
Journal:  Neurobiol Dis       Date:  2013-08-19       Impact factor: 5.996

7.  Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.

Authors:  Liliana B Menalled; Jessica D Sison; Ioannis Dragatsis; Scott Zeitlin; Marie-Françoise Chesselet
Journal:  J Comp Neurol       Date:  2003-10-06       Impact factor: 3.215

8.  'Super-Enrichment' Reveals Dose-Dependent Therapeutic Effects of Environmental Stimulation in a Transgenic Mouse Model of Huntington's Disease.

Authors:  Nektarios K Mazarakis; Christina Mo; Thibault Renoir; Anton van Dellen; Robert Deacon; Colin Blakemore; Anthony J Hannan
Journal:  J Huntingtons Dis       Date:  2014

9.  Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models.

Authors:  Liliana Menalled; Bassem F El-Khodor; Monica Patry; Mayte Suárez-Fariñas; Samantha J Orenstein; Benjamin Zahasky; Christina Leahy; Vanessa Wheeler; X William Yang; Marcy MacDonald; A Jennifer Morton; Gill Bates; Janet Leeds; Larry Park; David Howland; Ethan Signer; Allan Tobin; Daniela Brunner
Journal:  Neurobiol Dis       Date:  2009-05-21       Impact factor: 5.996

10.  Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease.

Authors:  Miriam A Hickey; Chunni Zhu; Vera Medvedeva; Renata P Lerner; Stefano Patassini; Nicholas R Franich; Panchanan Maiti; Sally A Frautschy; Scott Zeitlin; Michael S Levine; Marie-Françoise Chesselet
Journal:  Mol Neurodegener       Date:  2012-04-04       Impact factor: 14.195

View more
  8 in total

1.  Assessment of gait and sensorimotor deficits in the D1CT-7 mouse model of Tourette syndrome.

Authors:  Stephen C Fowler; Laura J Mosher; Sean C Godar; Marco Bortolato
Journal:  J Neurosci Methods       Date:  2017-01-15       Impact factor: 2.390

2.  Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

Authors:  Y Akkhawattanangkul; P Maiti; Y Xue; D Aryal; W C Wetsel; D Hamilton; S C Fowler; M P McDonald
Journal:  Genes Brain Behav       Date:  2017-04-18       Impact factor: 3.449

Review 3.  Neuroscience and actometry: An example of the benefits of the precise measurement of behavior.

Authors:  Troy J Zarcone
Journal:  Brain Res Bull       Date:  2022-04-25       Impact factor: 3.715

4.  Cholinergic interneurons in the Q140 knockin mouse model of Huntington's disease: Reductions in dendritic branching and thalamostriatal input.

Authors:  Yun-Ping Deng; Anton Reiner
Journal:  J Comp Neurol       Date:  2016-06-06       Impact factor: 3.215

Review 5.  Modeling tics in rodents: Conceptual challenges and paths forward.

Authors:  Marco Bortolato; Christopher Pittenger
Journal:  J Neurosci Methods       Date:  2017-02-22       Impact factor: 2.390

6.  Under or Absent Reporting of Light Stimuli in Testing of Anxiety-Like Behaviors in Rodents: The Need for Standardization.

Authors:  Lorenz S Neuwirth; Michael T Verrengia; Zachary I Harikinish-Murrary; Jessica E Orens; Oscar E Lopez
Journal:  Front Mol Neurosci       Date:  2022-08-17       Impact factor: 6.261

7.  Combined Effect of Bilateral Ovariectomy and Anterior Cruciate Ligament Transection With Medial Meniscectomy on the Development of Osteoarthritis Model.

Authors:  Jae Lim Kim; Chang Won Moon; Young Suk Son; Sang Jun Kim
Journal:  Ann Rehabil Med       Date:  2016-08-24

8.  OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.

Authors:  Beatrice Paola Festa; Marine Berquez; Alkaly Gassama; Irmgard Amrein; Hesham M Ismail; Marijana Samardzija; Leopoldo Staiano; Alessandro Luciani; Christian Grimm; Robert L Nussbaum; Maria Antonietta De Matteis; Olivier M Dorchies; Leonardo Scapozza; David Paul Wolfer; Olivier Devuyst
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.